About Alpha-1 antitrypsin Drugs
Alpha-1 antitrypsin, also known as an alpha-1 protease inhibitor (A1PI), is a glycoprotein produced in the liver that helps in the inactivation of enzymes such as elastase, which break down proteins during inflammation induced by some injury. The decline in alpha-1 antitrypsin levels in the blood results in a rare genetic condition known as alpha-1 antitrypsin deficiency (AATD), which leads to the development of respiratory and liver diseases, and severe skin infections. The disease is passed on from parents to an offspring through mutated genes. Augmentation therapy using drugs derived from human plasma helps in maintaining levels of alpha-1 antitrypsin in the blood, helping in remission of the condition.

Technavio’s analysts forecast the global alpha-1 antitrypsin drugs market to grow at a CAGR of 35.42% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global alpha-1 antitrypsin drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded drugs and off-label drugs used for the symptomatic treatment of diseases occurring due to alpha-1 antitrypsin deficiency and other disorders.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Alpha-1 Antitrypsin Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

α1-アンチトリプシン薬の世界市場2018-2022 IRTNTR21835 / Technavio / 2018年8月20日 / 当調査レポートでは、α1-アンチトリプシン薬の世界市場について調査・分析し、市場概要、市場環境、α1-アンチトリプシン薬市場規模、投与経路別（非経口、吸入）分析、市場動向、競争環境、主要地域別市場規模（北米、ヨーロッパ、アジアなど）、関連企業情報などを含め、以下の構成でお届け致します。主な分析対象企業は、Shire, CSL, GRIFOLS, and Kamadaなどです。 ・エグゼクティブサマリー ・調査範囲・調査手法 ・α1-アンチトリプシン薬の世界市場概要 ・α1-アンチトリプシン薬の世界市場環境 ・α1-アンチトリプシン薬の世界市場動向...About Alpha-1 Antitrypsin Drugs Alpha-1 antitrypsin augmentation therapy is used for treating emphysema caused due to deficiency of alpha-1 antitrypsin proteins in the bloodstream. Technavio’s analysts forecast the Global Alpha-1 Antitrypsin Drugs Market to grow at a CAGR of 10.64% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the alpha-1 antitrypsin drugs market. To calculate the market size, the report considers the revenue generated from the sales of alpha-1 antitrypsin drugs across the globe. The market is divided into the following segments based on geography: • Americas • APAC...

血友病治療薬の世界市場2016-2020 IRTNTR10470 / Technavio / 2016年10月19日 / 当調査レポートでは、血友病治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、血友病治療薬の世界市場規模及び予測、種類別分析、地域別分析/市場規模、購買基準、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Hemophilia Hemophilia is an X-linked genetic disorder that results in excessive blood loss during an injury, causing fatigue or even death. The disorder is more common in males and affects roughly 400,000 people globally every year. Hemophilia A is the more common form of this disorder, while hemophilia B is the rare form of hemophilia. To mitigate this disorder, plasma-derived clotting factors or recombinant clotting factors have been developed and are administered to the affected individual. The therapy is usually done in two ways: short acting therapeutic and long-acting therapeutic. Technavio’s analysts forecast the global hemophilia drugs market to...

疼痛治療薬の世界市場2016-2020 IRTNTR8628 / Technavio / 2016年8月1日 / 当調査レポートでは、疼痛治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疼痛治療薬の世界市場規模及び予測、種類別分析、薬剤種類別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。...About Pain Pain is defined as a complex medical problem that can have profound effects not only on one's physical but also mental well-being. Pain management is a branch of medicine, which employs approach for easing the suffering and improving the quality of life of individuals suffering from pain. It can be simple or complex type, depending on the cause of pain. Pain management comprises of a variety of skills and techniques used for the treatment of pain. Technavio’s analysts forecast the global pain management drugs market to grow at a CAGR of 4.97% during the period 2016-2020. [Covered in...

ヒトアルブミンの世界市場2016-2020 IRTNTR9576 / Technavio / 2016年6月27日 / 当調査レポートでは、ヒトアルブミンの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、ヒトアルブミンの世界市場規模及び予測、用途別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。...About the Human Albumin Market Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer's disease) are expected to enter the market during the forecast period. The demand for albumin is high in APAC in countries like India and China. Still, the uptake of these therapeutics is less due to the lack of awareness about these products and their therapeutic uses. Thus, the awareness programs...

特発性肺線維症（IPF）治療薬の世界市場2016-2020 IRTNTR8081 / Technavio / 2016年5月5日 / 当調査レポートでは、特発性肺線維症（IPF）治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、特発性肺線維症（IPF）治療薬の世界市場規模及び予測、薬剤種類別分析、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況などの情報をお届けいたします。...About Idiopathic Pulmonary Fibrosis Idiopathic pulmonary fibrosis belongs to a group of lung diseases known as interstitial lung diseases. It affects people in the age group 50-70 years. Diagnosis is effected by the exclusion of other interstitial lung diseases. High-resolution computed tomography (CT) is often employed to confirm the presence of the disease. There is no permanent cure for this disease; therefore, treatment involves relieving underlying symptoms. Nintedanib and pirfenidone are the two approved drugs for the treatment of idiopathic pulmonary fibrosis. Corticosteroids and immunosuppressive drugs are also used for the treatment. Technavio’s analysts forecast the global idiopathic pulmonary fibrosis...

偏頭痛治療薬の世界市場2016-2020 IRTNTR9324 / Technavio / 2016年5月2日 / 当調査レポートでは、偏頭痛治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、偏頭痛治療薬の世界市場規模及び予測、種類別分析、治療クラス別分析、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況などの情報をお届けいたします。...About Migraines A migraine is characterized by repeated attacks of a severe headache, nausea, vomiting, and extreme sensitivity to light and sound. Women are more prone to the disease compared to men owing to the fluctuating levels of hormones in their bodies. Therapeutic agents such as anti-inflammatory painkillers, antimigraine drugs, antisickness medicines, and triptans are used for the treatment of the disease. Technavio’s analysts forecast the global migraine drugs market to grow at a CAGR of 4.56% during the period 2016-2020. [Covered in this report] The report covers the present scenario and the growth prospects of the global migraine drugs...

プラズマ切断装置の世界市場2016-2020 IRTNTR8269 / Technavio / 2016年4月20日 / 当調査レポートでは、プラズマ切断装置の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、プラズマ切断装置の世界市場規模及び予測、需要先別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Plasma Cutting Machine Plasma cutting is used predominantly in the steel cutting industry. This process involves cutting conductive materials using a plasma arc that is generated inside a plasma torch. Based on the metal and desired quality levels, gases such as argon, nitrogen, argon and hydrogen (65%+35%), and compressed air are used as plasma gas. This cutting methodology is most widely used to cut aluminum, copper, thick stainless steel, and other alloys of steel. Even for ferrous materials such as mild steel, the quality of cutting achieved through this method is sharp and highly economical. The plasma cutting technology...

免疫グロブリン（Ig）製品の世界市場2016-2020 IRTNTR8965 / Technavio / 2016年4月13日 / 当調査レポートでは、免疫グロブリン（Ig）製品の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、免疫グロブリン（Ig）製品の世界市場規模及び予測、種類別分析、用途別分析、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。...About Immunoglobulin Products Immunoglobulins, also known as antibodies, are proteins that help neutralize foreign objects such as bacteria and viruses. They help recognize and bind to particular antigens. Based on the difference in the amino acid sequence in the fragment crystallizable (Fc) region of the antibody heavy chain, they can be categorized into the following isotypes: IgA, IgD, IgE, IgG, and IgM. In 1952, immunoglobulin products were used for the first time to treat immune deficiency. They can be administered by either the intravenous (IV) or subcutaneous (SC) route. Immunoglobulin products given intravenously usually contain IgG. Immunoglobulin products are used...

プレフィルドシリンジ（注射器）包装の世界市場2016-2020 IRTNTR8025 / Technavio / 2015年12月2日 / 当調査レポートでは、プレフィルドシリンジ（注射器）包装の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、プレフィルドシリンジ（注射器）包装の世界市場規模及び予測、用途別分析、材料別分析、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。...Technavios research analyst predicts the global prefilled syringe packaging market to grow at a CAGR of around 12% by 2020. The prefilled syringes are gaining popularity over parenteral drug delivery routes because of their high affordability, accuracy, and safety. Also, the ability of such syringes to reduce drug wastage, increase the useful drug lifespan, and increase the vendor's market footprint will result in the growth of the market. The augmented use of disposable medical products is the key driver for the growth of this market. Recently, it has been observed that many healthcare facilities prefer using disposable products as it...

世界のプラズマ（Plasma）市場動向（2012-2016） IRTNTR2054 / Technavio / 2013年3月26日 / ...TechNavio's analysts forecast the Global Plasma market to grow at a CAGR of 10.31 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the aging population. The Global Plasma market has also been witnessing the trend of increasing market consolidation. However, stringent regulations could pose a challenge to the growth of this market. TechNavio's report, the Global Plasma Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global...